BCWM LLC’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.36M | Buy |
110,424
+7,846
| +8% | +$451K | 1.86% | 24 |
|
|
2026
Q1 | $6.22M | Sell |
102,578
-6,883
| -6% | -$401K | 1.76% | 28 |
|
|
2025
Q4 | $5.9M | Buy |
109,461
+1,690
| +2% | +$81.3K | 1.77% | 24 |
|
|
2025
Q3 | $4.86M | Buy |
107,771
+1,700
| +2% | +$79.4K | 1.46% | 31 |
|
|
2025
Q2 | $4.91M | Buy |
106,071
+19,082
| +22% | +$937K | 1.56% | 27 |
|
|
2025
Q1 | $5.31M | Sell |
86,989
-23,290
| -21% | -$1.36M | 1.84% | 25 |
|
|
2024
Q4 | $6.24M | Buy |
+110,279
| New | +$6.16M | 2.22% | 20 |
|
|
2024
Q2 | $4.72M | Buy |
+113,658
| New | +$5.09M | 1.7% | 27 |
|
|
2018
Q2 | – | Sell |
-56,275
| Closed | -$3.56M | – | 74 |
|
|
2018
Q1 | $3.56M | Sell |
56,275
-8,224
| -13% | -$529K | 1.51% | 34 |
|
|
2017
Q4 | $3.95M | Sell |
64,499
-659
| -1% | -$41.2K | 1.61% | 29 |
|
|
2017
Q3 | $4.15M | Buy |
65,158
+150
| +0.2% | +$8.76K | 1.74% | 21 |
|
|
2017
Q2 | $3.62M | Sell |
65,008
-2,071
| -3% | -$113K | 1.61% | 30 |
|
|
2017
Q1 | $3.65M | Sell |
67,079
-432
| -0.6% | -$23.7K | 1.64% | 26 |
|
|
2016
Q4 | $3.95M | Buy |
67,511
+326
| +0.5% | +$17.8K | 1.84% | 21 |
|
|
2016
Q3 | $3.62M | Buy |
67,185
+2,341
| +4% | +$150K | 1.68% | 27 |
|
|
2016
Q2 | $4.77M | Buy |
64,844
+487
| +0.8% | +$34.4K | 2.29% | 7 |
|
|
2016
Q1 | $4.11M | Buy |
64,357
+29,938
| +87% | +$1.89M | 2.28% | 9 |
|
|
2015
Q4 | $2.37M | Sell |
34,419
-504
| -1% | -$33.3K | 1.43% | 30 |
|
|
2015
Q3 | $2.07M | Sell |
34,923
-9,179
| -21% | -$582K | 1.02% | 42 |
|
|
2015
Q2 | $2.94M | Sell |
44,102
-16,682
| -27% | -$1.1M | 1.23% | 30 |
|
|
2015
Q1 | $3.92M | Buy |
60,784
+741
| +1% | +$46.4K | 1.82% | 15 |
|
|
2014
Q4 | $3.54M | Sell |
60,043
-3,906
| -6% | -$220K | 1.71% | 18 |
|
|
2014
Q3 | $3.27M | Sell |
63,949
-1,233
| -2% | -$61.6K | 1.64% | 20 |
|
|
2014
Q2 | $3.16M | Buy |
65,182
+2,915
| +5% | +$144K | 1.61% | 23 |
|
|
2014
Q1 | $3.23M | Buy |
62,267
+2,360
| +4% | +$126K | 1.7% | 24 |
|
|
2013
Q4 | $3.18M | Sell |
59,907
-456
| -0.8% | -$23.2K | 1.8% | 22 |
|
|
2013
Q3 | $2.79M | Sell |
60,363
-16,018
| -21% | -$703K | 1.71% | 21 |
|
|
2013
Q2 | $3.41M | Buy |
+76,381
| New | +$3.32M | 2.07% | 11 |
|
Other funds holding BMY
BCWM LLC's BMY Position: Q2 2026 in Review
BCWM LLC increased its Bristol-Myers Squibb (BMY) stake by 7.6% in Q2 2026, buying an estimated $451K and bringing the position to 110,424 shares worth $6.36M. The position accounts for 1.86% of the portfolio, ranked #24.
BCWM LLC first reported a position in BMY in Q2 2013 and has held it in 28 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- BCWM LLC held 110,424 shares of Bristol-Myers Squibb worth $6.36M as of Q2 2026.
- BCWM LLC bought 7,846 Bristol-Myers Squibb shares in Q2 2026, an estimated $451K.
- Bristol-Myers Squibb made up 1.86% of BCWM LLC's portfolio in Q2 2026, its #24 holding.
- BCWM LLC first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 28 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on BCWM LLC's 13F filing for Q2 2026, filed 14 Aug 2026.